MIMS (Philippines) drug information results matching Prozelax
User Information
NEWS | CME 
 Researchers in Asia point to better sepsis treatments   The JUPITER trial: Do the results apply to Asians?   Conflicting Recommendations for Lipid Screening and Management in Children: The Need for Consensus   Asian lung cancer vaccine trial resumes after temporary hold   7th International Symposium on Respiratory Diseases (ISRD)   Type 1 Diabetes Mellitus in Children and Adolescents   Community-based lifestyle intervention beneficial in Chinese diabetes, hypertension patients   Gefitinib improves progression-free survival in NSCLC with EGFR mutations   Non-HDL Cholesterol: When and how to Treat   Recommendations for the Management of Neuropathic Pain Associated With Peripheral Nerve Entrapment   Coronary CT predicts future cardiac events   Linagliptin lowers blood sugar in type 2 diabetics   Women's heart attacks differ from men's   Chinese women largely unaware of heart disease and stroke risk   Ethnicity is a strong indicator of cardiovascular risk   
MIMS Info PubMed
Results 1-1 of 1 for Prozelax (0 seconds)
Other(s): China  HK  India  Indonesia  Malaysia  Phil  S'pore  Taiwan  Thai  US  Vietnam  ALL  
Display: Brief  Full      Search in: Drug Only  All  
Prozelax cap® [ Biomedis ]  [ United Lab ] - tamsulosin
Indication: Treatment of the signs & symptoms of BPH including bladder outlet obstruction.
MIMS Class: Drugs for Bladder & Prostate Disorders 
Interaction  Patient MedInfo  Search PubMed  

 
  
 
China MIMS Online Home Page Hong Kong MIMS Online Home Page India MIMS Online Home Page Indonesia MIMS Online Home Page Malaysia MIMS Online Home Page Philippines MIMS Online Home Page Singapore MIMS Online Home Page Taiwan MIMS Online Home Page Thailand MIMS Online Home Page Vietnam MIMS Online Home Page